Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Aug 8;14(16):1721.
doi: 10.3390/diagnostics14161721.

Improving the Diagnosis of Autoimmune Gastritis: From Parietal Cell Antibodies to H+/K+ ATPase Antibodies

Affiliations
Review

Improving the Diagnosis of Autoimmune Gastritis: From Parietal Cell Antibodies to H+/K+ ATPase Antibodies

Michela Tonegato et al. Diagnostics (Basel). .

Abstract

Parietal cell autoantibodies (PCAs), which recognize the enzyme H+/K+-ATPase as a target, are considered to be a diagnostic marker of autoimmune gastritis and pernicious anemia; these conditions are characterized by the presence of corpus atrophic gastritis. Circulating PCAs can be detected using several analytical methods that are commonly available in the clinical laboratory. Traditionally, indirect immunofluorescence (IIF) on rodent or primate stomach tissue is used as a screening test for the detection of PCAs. However, IIF suffers from a high inter-observer variability and lacks standardization. In addition, like immunoblotting, results are expressed only in a qualitative or semi-quantitative manner. Based on the few available studies that are reviewed herein, quantitative enzyme-linked immunosorbent assays (ELISAs) and fluorescence enzyme immunoassays (FEIAs) using purified H+/K+-ATPase perform better than IIF in the detection of PCAs, displaying higher sensitivity and utility in monitoring the disease. In light of their higher diagnostic accuracy, these solid-phase methods should be preferred to IIF in the screening of autoimmune atrophic gastritis. The use of methods to detect antibodies versus a specific subunit of H+/K+-ATPase (α or β) is currently confined to the world of research. Further investigation is required to define the clinical utility of H+/K+-ATPase subunit detection.

Keywords: H+/K+-ATPase; autoimmune gastritis; chronic atrophic gastritis; immunoassays; parietal cell autoantibodies.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Positive fluorescence pattern for antibodies against gastric parietal cells (PCAs) obtained after incubation of the cell substrate (mouse stomach section) with serum from a patient with chronic atrophic autoimmune gastritis. The typical picture is indicated by diffuse fluorescence in gastric parietal cell cytoplasm, while the nuclei are negative. Also negative are the zymogenic cells (indirect immunofluorescence 1:40, 400×).

Similar articles

Cited by

References

    1. Di Sabatino A., Lenti M.V., Giuffrida P., Vanoli A., Corazza G.R. New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract. Autoimmun. Rev. 2015;14:1161–1169. doi: 10.1016/j.autrev.2015.08.004. - DOI - PubMed
    1. Rustgi S.D., Bijlani P., Shah S.C. Autoimmune gastritis, with or without pernicious anemia: Epidemiology, risk factors, and clinical management. Ther. Adv. Gastroenterol. 2021;14:17562848211038771. doi: 10.1177/17562848211038771. - DOI - PMC - PubMed
    1. Lenti M.V., Rugge M., Lahner E., Miceli E., Toh B.H., Genta R., De Block C., Hershko C., Di Sabatino A. Autoimmune gastritis. Nat. Rev. Dis. Primers. 2020;6:56. doi: 10.1038/s41572-020-0187-8. - DOI - PubMed
    1. Rusak E., Chobot A., Krzywicka A., Wenzlau J. Anti-parietal cell antibodies—Diagnostic significance. Adv. Med. Sci. 2016;61:175–179. doi: 10.1016/j.advms.2015.12.004. - DOI - PubMed
    1. Massironi S., Zilli A., Elvevi A., Invernizzi P. The changing face of chronic autoimmune atrophic gastritis: An updated comprehensive perspective. Autoimmun. Rev. 2019;18:215–222. doi: 10.1016/j.autrev.2018.08.011. - DOI - PubMed

LinkOut - more resources